trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['gyn', 'bcsm', 'blcsm', 'pancsm', 't-dxd']
study finds t-dxd effectively treats her2-expressing cancers, regardless of tumor location #oncology #immunotherapy #pancsm #gyncsm #hpbcsm #blcsm #asco23
News and views from the world of clinical oncology and hematology